Legal & General Group Plc Acquires 31,031 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Legal & General Group Plc grew its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 577.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 36,409 shares of the company’s stock after purchasing an additional 31,031 shares during the quarter. Legal & General Group Plc’s holdings in Aveanna Healthcare were worth $166,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in AVAH. Federated Hermes Inc. lifted its holdings in shares of Aveanna Healthcare by 3,047.2% during the fourth quarter. Federated Hermes Inc. now owns 89,665 shares of the company’s stock valued at $410,000 after purchasing an additional 86,816 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Aveanna Healthcare during the 4th quarter valued at about $65,000. Wells Fargo & Company MN increased its holdings in Aveanna Healthcare by 42.1% during the fourth quarter. Wells Fargo & Company MN now owns 26,368 shares of the company’s stock valued at $121,000 after buying an additional 7,814 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Aveanna Healthcare by 15.4% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 282,876 shares of the company’s stock worth $1,293,000 after purchasing an additional 37,801 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of Aveanna Healthcare by 80.5% during the 4th quarter. JPMorgan Chase & Co. now owns 154,703 shares of the company’s stock valued at $707,000 after buying an additional 68,989 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total value of $339,217.64. Following the completion of the sale, the insider now directly owns 1,453,948 shares of the company’s stock, valued at $8,011,253.48. This trade represents a 4.06 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold a total of 67,412 shares of company stock worth $372,142 in the last 90 days. Corporate insiders own 7.80% of the company’s stock.

Aveanna Healthcare Price Performance

NASDAQ:AVAH opened at $4.50 on Friday. The firm has a market capitalization of $877.92 million, a P/E ratio of -13.23 and a beta of 1.99. The company’s fifty day moving average price is $4.73 and its 200-day moving average price is $4.90. Aveanna Healthcare Holdings Inc. has a 1-year low of $2.20 and a 1-year high of $6.19.

Wall Street Analysts Forecast Growth

AVAH has been the topic of several recent analyst reports. UBS Group lifted their price objective on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a research report on Friday, March 14th. Truist Financial decreased their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, April 11th.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.